Maestro by Moon Surgical: status and timeline

Milestones

Next · Roll-out of v2.7 across installed base

Company founded2020Complete.
First FDA 510(k) clearance and first-in-human studyDec 2022Complete.
CE mark for the commercial system2023Complete.
First US clinical casesSep 2023Complete.
FDA clearance of the commercial Maestro systemJun 2024Complete.
ScoPilot AI camera control cleared by FDA18 Mar 2025Complete.
Wi-Fi/5G connectivity and ScoPilot change-control plan clearedJul 2025Complete.
Software v2.7: automated set-up, third-party AI apps9 Jun 2026Complete.
Roll-out of v2.7 across installed baseTarget 2026Current milestone.

Most important updates

Upcoming

2026Roll-out of v2.7 across installed base (next)

Current obstacles

Regulating learning softwareAI features that improve over time need an FDA-approved change plan; ScoPilot got one in 2025, but each new capability still needs validation.
Patient data in AI trainingRecording video and motion in the OR raises consent and data-governance questions as the dataset grows.

Physics limits

Seeing only through the cameraVision models see what one laparoscope shows; smoke, blood and fogging hide instruments, so automated camera control must fall back to the surgeon.
Hand-held surgery's limits remainThe surgeon still operates with straight hand instruments, so Maestro adds steadiness and camera control, not the wristed dexterity of a full robot.

How it works

4 parts

Arms

Two arms that lock where you leave them

The surgeon positions each arm by hand; it feels weightless while moving and locks rigidly when released, holding a scope or retractor steady.

Instruments

Uses the surgeon's own tools

Maestro holds most standard 5-10 mm laparoscopic instruments and scopes, so hospitals keep their existing kit and technique.

ScoPilot

Camera follows the instrument tip

On demand, a vision model tracks the tip of a chosen instrument and moves the laparoscope to keep it centred, without the surgeon letting go of their tools.

Data

Recording every case

Sensors and arm motion data from each case build a dataset used to train and validate new automation, such as automatic set-up.

Spec sheet

Spec	Maestro
Robotic arms	2^R (reported)
Instrument compatibility	Most 5-10 mm instruments and scopes^R (reported)
Patients treated (Mar 2025)	1,100+^R (reported)
Procedure dataset (Jun 2026)	3,000+ procedures^R (reported)
Surgeon learning curve	3-5 procedures^R (reported)

^R reported by the company

Papers & demos

1 item

2023paper
First-in-human study of the Maestro system (Surgical Endoscopy) (opens link.springer.com)Peer-reviewed first clinical use of the co-manipulation arms in laparoscopy.

Update log

2 updates

Tue 9 Jun

Minor: Moon Surgical ships Maestro software 2.7 with automated set-up and the first third-party AI appPressSoftware

Tue 18 Mar 2025

Major: FDA clears Moon Surgical's ScoPilot, an AI feature that makes Maestro's camera follow the surgeon's instrumentPressRegulatory

About Moon Surgical

The team behind Maestro

Moon Surgical

Maestro surgical assistant robot, ScoPilot AI

Franco-American company, founded in 2020 and based in Paris and San Francisco, making Maestro: a bedside robot that holds the camera and retractors in keyhole surgery so the surgeon works with their usual instruments.

Maestro is an assistant, not a replacement robot: two arms hold the camera and instruments while the surgeon operates normally.
ScoPilot (FDA-cleared Mar 2025) makes the camera follow the surgeon's instrument tip, running on NVIDIA Holoscan.
Over 1,100 patients treated by March 2025; a dataset of 3,000+ procedures trains its AI (June 2026).

moonsurgical.com (opens moonsurgical.com)Company profile →

Founded: 20206 yrs
Headquarters: FranceUnited States
Status: Private
Valuation: private
Works in: RoboticsKeyhole surgery robotsAI
Coverage: 1 program · 2 updateslatest 9 Jun 2026checked 11 Oct
Customers: Lee Health (opens prnewswire.com)
Partners: NVIDIA
Investors: Sofinnova Partners
People: Anne OsdoitCEO